Asunra 400MG Tablet, which contains the active ingredient Deferasirox at a dosage of 400mg, is a medication primarily used for the treatment of chronic iron overload due to blood transfusions in patients with conditions such as thalassemia or sickle cell disease. This oral tablet is designed to help reduce excess iron accumulation in the body, which can lead to serious complications affecting the heart, liver, and endocrine organs. Asunra works by binding to free iron in the bloodstream, facilitating its excretion through the gastrointestinal tract. The formulation is available in a pack of six tablets, making it convenient for patients to manage their treatment regimen. Asunra is an essential part of iron chelation therapy, helping to improve the quality of life for patients suffering from iron overload while minimizing the risk of organ damage.